Throughout the second quarter of 2023, the pricing of Ofloxacin in the North American region displayed a mixed trajectory. The quarter began with a continuation of the previous month's market trend, leading to a steady rise in inquiries from the domestic pharmaceutical and healthcare sectors. However, by May, Ofloxacin prices experienced a 2% decrease from the previous month. This decline was influenced by a combination of reduced demand, increased supply, and a weakening currency. The USA observed a decline in Ofloxacin prices due to heightened stocks from China and India, both major suppliers of Pharmaceutical APIs, including Ofloxacin.